Eleven Biotherapeutics Inc. (EBIO) Sees Large Volume Increase
Eleven Biotherapeutics Inc. (NASDAQ:EBIO) saw an uptick in trading volume on Friday . 14,433,729 shares traded hands during mid-day trading, an increase of 323% from the previous session’s volume of 3,414,570 shares.The stock last traded at $2.62 and had previously closed at $1.96.
The firm’s market cap is $38.17 million. The firm has a 50-day moving average price of $1.88 and a 200 day moving average price of $1.13.
In other news, major shareholder Boxer Capital, Llc sold 1,042,000 shares of the stock in a transaction dated Monday, June 13th. The shares were sold at an average price of $2.74, for a total transaction of $2,855,080.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Eleven Biotherapeutics, Inc is a clinical-stage biopharmaceutical company. The Company through AMP-Rx, a protein engineering platform, is engaged in the discovery and development of protein therapeutics to treat diseases of the eye. The Company designs, engineers and generates a pipeline of protein therapeutic candidates that target cytokines, which are central to diseases of the eye.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.